Fidelity Investments’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
Fidelity Investments's ATEX Position: Q3 2026 in Review
Fidelity Investments reduced its Anterix (ATEX) stake by 49% in Q3 2026, selling an estimated $16.9M and leaving 187,132 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1994.
Fidelity Investments first reported a position in ATEX in Q1 2021 and has held it in 23 quarters since. The position peaked at $38.1M in Q2 2026. 172 funds tracked by Wall St. Rank hold ATEX as of Q3 2026.
- Fidelity Investments held 187,132 shares of Anterix worth $14.7M as of Q3 2026.
- Fidelity Investments sold 183,268 Anterix shares in Q3 2026, an estimated $16.9M.
- Anterix made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #1994 holding.
- Fidelity Investments first reported a position in Anterix in Q1 2021 and has held it in 23 quarters since.
- Fidelity Investments's Anterix position peaked at $38.1M in Q2 2026.
- 172 funds tracked by Wall St. Rank held Anterix as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.